TCM
CGON icon

TCG Crossover Management’s CG Oncology CGON Stock Holding History

TCG Crossover Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261M Hold
3,670,206
– – 6.27% 3
2026
Q1 		$248M Hold
3,670,206
– – 7.11% 2
2025
Q4 		$152M Hold
3,670,206
– – 5.04% 3
2025
Q3 		$148M Hold
3,670,206
– – 7.27% 2
2025
Q2 		$95.4M Hold
3,670,206
– – 10.9% 1
2025
Q1 		$89.9M Hold
3,670,206
– – 12.26% 1
2024
Q4 		$105M Hold
3,670,206
– – 10.29% 1
2024
Q3 		$138M Hold
3,670,206
– – 11.73% 1
2024
Q2 		$116M Buy
3,670,206
+100,000
+3% +$3.47M 12.08% 1
2024
Q1 		$157M Buy
+3,570,206
New +$146M 12.39% 1

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCG Crossover Management's CGON Position: Q2 2026 in Review

TCG Crossover Management held its CG Oncology (CGON) position steady in Q2 2026 at 3,670,206 shares worth $261M. The position accounts for 6.27% of the portfolio, ranked #3.

TCG Crossover Management first reported a position in CGON in Q1 2024 and has held it in 10 quarters since. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • TCG Crossover Management held 3,670,206 shares of CG Oncology worth $261M as of Q2 2026.
  • TCG Crossover Management left its CG Oncology share count unchanged in Q2 2026.
  • CG Oncology made up 6.27% of TCG Crossover Management's portfolio in Q2 2026, its #3 holding.
  • TCG Crossover Management first reported a position in CG Oncology in Q1 2024 and has held it in 10 quarters since.
  • 228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on TCG Crossover Management's 13F filing for Q2 2026, filed 14 Aug 2026.